Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic
Publication: OMICS: A Journal of Integrative Biology
Volume 26, Issue Number 9
Abstract
COVID-19 is a systemic disease affecting multiple organ systems and caused by infection with the SARS-CoV-2 virus. Two years into the COVID-19 pandemic and after the introduction of several vaccines, the pandemic continues to evolve in part owing to global inequities in access to preventive and therapeutic measures. We are also witnessing the introduction of antivirals against COVID-19. Against this current background, we review the progress made with nanotechnology-based approaches such as nanoformulations to combat the multiorgan effects of SARS-CoV-2 infection from a systems medicine lens. While nanotechnology has previously been widely utilized in the antiviral research domain, it has not yet received the commensurate interest in the case of COVID-19 pandemic response strategies. Notably, SARS-CoV-2 and nanomaterials are similar in size ranging from 50 to 200 nm. Nanomaterials offer the promise to reduce the side effects of antiviral drugs, codeliver multiple drugs while maintaining stability in the biological milieu, and sustain the release of entrapped drug(s) for a predetermined time period, to name but a few conceivable scenarios, wherein nanotechnology can enable and empower preventive medicine and therapeutic innovations against SARS-CoV-2. We conclude the article by underlining that nanotechnology-based interventions warrant further consideration to enable precision planetary health responses against the COVID-19 pandemic.
Get full access to this article
View all available purchase options and get full access to this article.
References
Aasi A, Aghaei SM, Moore MD, et al. Pt-, Rh-, Ru-, and Cu-single-wall carbon nanotubes are exceptional candidates for design of anti-viral surfaces: A theoretical study. Int J Mol Sci 2020;21(15):5211;.
Ahmad Z, Shah A, Siddiq M, et al. Polymeric micelles as drug delivery vehicles. RSC Adv 2014;4(33):17028–17038;.
Aldosari BN, Alfagih IM, Almurshedi AS. Lipid nanoparticles as delivery systems for RNA-based vaccines. Pharmaceutics 2021;13(2):206;.
Al-Taie A, Denkdemir FR, Sharief Z, et al. The long view on COVID-19 theranostics and oral antivirals: Living with endemic disease and lessons from molnupiravir. OMICS 2022;26(6):324–328;.
Aminian A, Safari S, Razeghian-Jahromi A, et al. COVID-19 outbreak and surgical practice: Unexpected fatality in perioperative period. Ann Surg 2020;272(1):e27–e29;.
Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update. Bioeng Transl Med 2019;4(3):e10143;.
Aragao-Santiago L, Hillaireau H, Grabowski N, et al. Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles. Nanotoxicology 2016;10(3):292–302;.
Asif M, Ajmal M, Ashraf G, et al. The role of biosensors in coronavirus disease-2019 outbreak. Curr Opin Electrochem 2020;23:174–184;.
Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020;323(14):1406–1407;.
Baram-Pinto D, Shukla S, Gedanken A, et al. Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles. Small 2010;6(9):1044–1050;.
Bawa R, Audette GF, Rubinstein I. Handbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy, and Clinical Applications (Vol. 1). CRC Press; 2016.
Behera A, Padhi S. Passive and active targeting strategies for the delivery of the camptothecin anticancer drug: A review. Environ Chem Lett 2020;18(5):1557–1567;.
Bhattacharya K, Mukherjee SP, Gallud A, et al. Biological interactions of carbon-based nanomaterials: From coronation to degradation. Nanomedicine 2016;12(2):333–351;.
Cagno V, Andreozzi P, D'Alicarnasso M, et al. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat Mater 2018;17(2):195–203;.
Campos EVR, Pereira AES, de Oliveira JL, et al. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. J Nanobiotechnology 2020;18(1):125;.
Chan WCW. Nano research for COVID-19. ACS Nano 2020;14(4):3719–3720;.
Chauhan G, Madou MJ, Kalra S, et al. Nanotechnology for COVID-19: Therapeutics and vaccine research. ACS Nano 2020;14(7):7760–7782;.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507–513;.
Chen W-H, Strych U, Hotez PJ, et al. The SARS-CoV-2 Vaccine. Pipeline: An Overview. Curr Trop Med Rep 2020;7(2):61–64;.
Chuan J, Li Y, Yang L, et al. Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles. J Nanopart Res 2013;15(5):1–9;.
Chung YH, Beiss V, Fiering SN, et al. COVID-19 vaccine frontrunners and their nanotechnology design. ACS Nano 2020;14(10):12522–12537;.
Clayton R, Ohagen A, Nicol F, et al. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes. Antiviral Res 2009;84(2):142–149;.
Dalawai SP, Aly MAS, Latthe SS, et al. Recent advances in durability of superhydrophobic self-cleaning technology: A critical review. Prog Org Coat 2020;138:105381;.
Dey J, Mahapatra SR, Lata S, et al. Exploring Klebsiella pneumoniae capsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia. Expert Rev Vaccines 2022;39(42):6221–6237;.
Dey J, Mahapatra SR, Singh P, et al. B and T cell epitope-based peptides predicted from clumping factor protein of Staphylococcus aureus as vaccine targets. Microb Pathog 2021;160:105171;.
Dormont F, Brusini R, Cailleau C, et al. Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents. Sci Adv 2020;6(23):eaaz5466;.
Eatemadi A, Daraee H, Karimkhanloo H, et al. Carbon nanotubes: Properties, synthesis, purification, and medical applications. Nanoscale Res Lett 2014;9(1):1–13;.
Elmezayen AD, Al-Obaidi A, Şahin AT, et al. Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J Biomol Struct Dyn 2021;39(8):2980–2992;.
El-Nahhal IM, Salem J, Anbar R, et al. Preparation and antimicrobial activity of ZnO-NPs coated cotton/starch and their functionalized ZnO-Ag/cotton and Zn (II) curcumin/cotton materials. Sci Rep 2020;10(1):1–10;.
Elston DM. Occupational skin disease among health care workers during the coronavirus (COVID-19) epidemic. J Am Acad Dermatol 2020;82(5):1085–1086;.
Galdiero S, Falanga A, Vitiello M, et al. Silver nanoparticles as potential antiviral agents. Molecules 2011;16(10):8894–8918;.
Ge Q, Filip L, Bai A, et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci U S A 2004;101(23):8676–8681;.
Habibzadeh P, Mofatteh M, Silawi M, et al. Molecular diagnostic assays for COVID-19: An overview. Crit Rev Clin Lab Sci 2021;58(6):385–398;.
Hardinge P, Murray JAH. Reduced false positives and improved reporting of loop-mediated isothermal amplification using quenched fluorescent primers. Sci Rep 2019;9(1):1–13;.
Hassan N, Firdaus S, Padhi S, et al. Investigating natural antibiofilm components: A new therapeutic perspective against candidal vulvovaginitis. Med Hypotheses 2021;148:110515;.
Herron JBT, Hay-David AGC, Gilliam AD, et al. Personal protective equipment and Covid 19—A risk to healthcare staff? Br J Oral Maxillofac Surg 2020;58(5):500–502;.
Hojyo S, Uchida M, Tanaka K, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen 2020;40(1):1–7;.
Hussain M, Raja NI, Mashwani ZU, et al. In vitro seed germination and biochemical profiling of Artemisia absinthium exposed to various metallic nanoparticles. 3 Biotech 2017;7(2):1–8;.
Jayamohan H, Lambert CJ, Sant HJ, et al. SARS-CoV-2 pandemic: A review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations. Anal Bioanal Chem 2021;413(1):49–71;.
Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med 2022;386(6):509–520;.
Jeremiah SS, Miyakawa K, Morita T, et al. Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochem Biophys Res Commun 2020;533(1):195–200;.
Kampf G. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents. Infect Prev Pract 2020;2(2):100044;.
Kandeel M, Al-Nazawi M. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sci 2020;251:117627;.
Kandeel M, Al-Taher A, Park BK, et al. A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus. J Med Virol 2020;92(9):1665–1670;.
Kang S, Peng W, Zhu Y, et al. Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: Detection, mechanisms and treatment. Int J Antimicrob Agents 2020;55(5):105950;.
Keech C, Albert G, Cho I, et al. Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine. N Engl J Med 2020;383(24):2320–2332;.
Khan RJ, Jha RK, Amera GM, et al. Targeting novel coronavirus 2019: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 20-O-ribose methyltransferase. J Biomol Struct Dyn 2020;39(8):2679–2692;.
Khuroo T, Verma D, Talegaonkar S, et al. Topotecan–tamoxifen duple PLGA polymeric nanoparticles: Investigation of in vitro, in vivo and cellular uptake potential. Int J Pharm 2014;473(1–2):384–394;.
Kim JO, Sahay G, Kabanov AV, et al. Polymeric micelles with ionic cores containing biodegradable cross-links for delivery of chemotherapeutic agents. Biomacromolecules 2010;11(4):919–926;.
Kolyvushko O, Latzke J, Dahmani I, et al. Differentially-charged liposomes interact with alphaherpesviruses and interfere with virus entry. Pathogens 2020;9(5):359;.
Kong N, Tao W, Ling X, et al. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition. Sci Transl Med 2019;11(523):eaaw1565;.
Kumar A, Pandey AN, Jain SK. Nasal-nanotechnology: Revolution for efficient therapeutics delivery. Drug Deliv 2016;23(3):671–683;.
Lee JH, Yeo Y. Controlled drug release from pharmaceutical nanocarriers. Chem Eng Sci 2015;125:75–84;.
Li T, Zheng Q, Yu H, et al. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates. Emerg Microbes Infect 2020;9(1):2076–2090;.
Łoczechin A, Séron K, Barras A, et al. Functional carbon quantum dots as medical countermeasures to human coronavirus. ACS Appl Mater Interfaces 2019;11(46):42964–42974;.
Luo C, Sun J, Sun B, et al. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. Trends Pharmacol Sci 2014;35(11):556–566;.
Mahapatra SR, Dey J, Kaur T, et al. Immunoinformatics and molecular docking studies reveal a novel multi-epitope peptide vaccine against pneumonia infection. Vaccine 2021;39(42):6221–6237;.
Maherani B, Arab-Tehrany E, R Mozafari M, et al. Liposomes: A review of manufacturing techniques and targeting strategies. Curr Nanosci 2011;7(3):436–452;.
Mainardes RM, Diedrich C. The potential role of nanomedicine on COVID-19 therapeutics. Ther Deliv 2020;11(7):411–414;.
Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 2011;3(3):1377–1397;.
Manjunath K, Reddy JS, Venkateswarlu V. Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol 2005;27(2):127–144;.
Mansi A, Boccuni F, Iavicoli S. Nanomaterials as a new opportunity for protecting workers from biological risk. Ind Health 2019;57(6):668–675;.
Marassi V, Di Cristo L, Smith SGJ, et al. Silver nanoparticles as a medical device in healthcare settings: A five-step approach for candidate screening of coating agents. R Soc Open Sci 2018;5(1):171113;.
Mehta P, McAuley DF, Brown M, et al. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020;395(10229):1033–1034.
Mhlwatika Z, Aderibigbe BA. Application of dendrimers for the treatment of infectious diseases. Molecules 2018;23(9):2205;.
Mody VV, Siwale R, Singh A, et al. Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2010;2(4):282;.
Moitra P, Alafeef M, Dighe K, et al. Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles. ACS Nano 2020;14(6):7617–7627;.
Naseri N, Valizadeh H, Zakeri-Milani P. Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Adv Pharm Bull 2015;5(3):305;.
Ohno S, Kohyama S, Taneichi M, et al. Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A* 0201 transgenic mice. Vaccine 2009;27(29):3912–3920;.
Padhi S, Kapoor R, Verma D, et al. Formulation and optimization of topotecan nanoparticles: In vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes. J Photochem Photobiol B 2018;183:222–232;.
Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: A review on recent drug based therapeutics. Biomed Pharmacother 2020;131:110708;.
Park GS, Ku K, Baek SH, et al. Development of reverse transcription loop-mediated isothermal amplification assays targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J Mol Diagn 2020;22(6);729–735;.
Patnaik S, Gorain B, Padhi S, et al. Recent update of toxicity aspects of nanoparticulate systems for drug delivery. Eur J Pharm Biopharm 2021;161:100–119;.
Patoo TS, Khanday F, Qurashi A. Prospectus of advanced nanomaterials for antiviral properties. Mater Adv 2022;3(7):2960–2970;.
Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: Recent developments and future prospects. J Nanobiotechnology 2018;16(1):1–33;.
Prasanna P, Rathee S, Upadhyay A, et al. Nanotherapeutics in the treatment of acute respiratory distress syndrome. Life Sci 2021;276:119428;.
Pulendran B, Arunachalam PS, O'Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov 2021;20(6):454–475;.
Rabiee N, Bagherzadeh M, Ghasemi A, et al. Point-of-use rapid detection of SARS-CoV-2: Nanotechnology-enabled solutions for the COVID-19 pandemic. Int J Mol Sci 2020;21(14):5126;.
Rastogi M, Pandey N, Shukla A, et al. SARS coronavirus 2: From genome to infectome. Respir Res 2020;21(1):318;.
Rauch S, Roth N, Schwendt K, et al. mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents. NPJ Vaccines 2021;6(1):1–9;.
Rawat K, Kumari P, Saha L. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol 2021;892:173751;.
Revuelta-Herrero JL, Chamorro-de-Vega E, Rodríguez-González CG, et al. Effectiveness, safety, and costs of a treatment switch to dolutegravir plus rilpivirine dual therapy in treatment-experienced HIV patients. Ann Pharmacother 2018;52(1):11–18;.
Rudolf F, Kaltenbach HM, Linnik J, et al. Clinical characterisation of eleven lateral flow assays for detection of COVID-19 antibodies in a population. MedRxiv 2020;.
Salleh A, Naomi R, Utami ND, et al. The potential of silver nanoparticles for antiviral and antibacterial applications: A mechanism of action. Nanomaterials (Basel) 2020;10(8):1566;.
Schöttler S, Becker G, Winzen S, et al. Protein adsorption is required for stealth effect of poly (ethylene glycol)-and poly (phosphoester)-coated nanocarriers. Nat Nanotechnol 2016;11(4):372–377;.
Shah B, Modi P, Sagar SR. In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sci 2020;252:117652;.
Sheahan TP, Sims AC, Leist SR, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 2020;11(1):1–14;.
Sidiq Z, Hanif M, Dwivedi KK, et al. Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberc 2020;67(4):S163–S166;.
Singh L, Kruger HG, Maguire GEM, et al. The role of nanotechnology in the treatment of viral infections. Ther Adv Infect Dis 2017;4(4):105–131;.
Singh P, Singh D, Sa P, et al. Insights from nanotechnology in COVID-19: Prevention, detection, therapy and immunomodulation. Nanomedicine (Lond) 2021;6(14):1219–1235;.
Soiza RL, Donaldson AIC, Myint PK. The pale evidence for treatment of iron-deficiency anaemia in older people. Ther Adv Drug Saf 2018;9(6):259–261;.
Song X, Lin Q, Guo L, et al. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery. Pharm Res 2015;32(5):1741–1751;.
Soy M, Keser G, Atagündüz P, et al. Cytokine storm in COVID-19: Pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 2020;39(7):2085–2094;.
Spagnol C, Fragal EH, Pereira AGB, et al. Cellulose nanowhiskers decorated with silver nanoparticles as an additive to antibacterial polymers membranes fabricated by electrospinning. J Colloid Interface Sci 2018;531:705–715;.
Strasfeld L, Chou S. Antiviral drug resistance: Mechanisms and clinical implications. Infect Dis Clin North Am 2010;24(3):809–833;.
Su S, Kang PM. Recent advances in nanocarrier-assisted therapeutics delivery systems. Pharmaceutics 2020;12(9):837;.
Sun X, Wang T, Cai D, et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev 2020;53:38–42;.
Tian JH, Patel N, Haupt R, et al. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nat Commun 2021;12(1):1–14;.
Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4(2):145–160;.
Tran NQ, Nguyen CK, Nguyen TP. Dendrimer-based nanocarriers demonstrating a high efficiency for loading and releasing anticancer drugs against cancer cells in vitro and in vivo. Adv Nat Sci Nanosci Nanotechnol 2013;4(4):045013.
Tripathy S, Das MK. Dendrimers and their applications as novel drug delivery carriers. J Appl Pharm Sci 2013;3(9):142–149.
Trzebicka B, Szweda D, Rangelov S, et al. (Co) polymers of oligo (ethylene glycol) methacrylates—Temperature-induced aggregation in aqueous solution. J Polym Sci A Polym Chem 2013;51(3):614–623.
van der Poll T, Van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 2017;17(7):407–420;.
Volz E, Mishra S, Chand M, et al. Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data. Nature 2021;593(7858):266–269;.
Wadhwa A, Aljabbari A, Lokras A, et al. Opportunities and challenges in the delivery of mRNA-based vaccines. Pharmaceutics 2020;12(2):102;.
Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020;181(2):281–292;.
Wang H, Zhu W, Feng L, et al. Nanoscale covalent organic polymers as a biodegradable nanomedicine for chemotherapy-enhanced photodynamic therapy of cancer. Nano Res 2018;11(6):3244–3257;.
Weissleder R, Lee H, Ko J, et al. COVID-19 diagnostics in context. Sci Transl Med 2020;12(546):eabc1931;.
Xu G, Mahajan S, Roy I, et al. Theranostic quantum dots for crossing blood-brain barrier in vitro and providing therapy of HIV-associated encephalopathy. Front Pharmacol 2013;4:140;.
Yang J. Inhibition of SARS-CoV-2 replication by acidizing and RNA lyase-modified carbon nanotubes combined with photodynamic thermal effect. J Explor Res Pharmacol 2020;5(2):18–23;.
Yang J, Yue L, Yang Z, et al. Metal-based nanomaterials: Work as drugs and carriers against viral infections. Nanomaterials (Basel) 2021;11(8):2129;.
Yavuz B, Morgan JL, Showalter L, et al. Pharmaceutical approaches to HIV treatment and prevention. Adv Ther (Weinh) 2018;1(6):1800054;.
Yeh YT, Gulino K, Zhang Y, et al. A rapid and label-free platform for virus capture and identification from clinical samples. Proc Natl Acad Sci U S A 2020;117(2):895–901;.
Yetisen AK, Qu H, Manbachi A, et al. Nanotechnology in textiles. ACS Nano 2016;10(3):3042–3068;.
Yu L, Wu S, Hao X, et al. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform. Clin Chem 2020;66(7):975–977;.
Zhong H, Zhu Z, Lin J, et al. Reusable and recyclable graphene masks with outstanding superhydrophobic and photothermal performances. ACS Nano 2020;14(5):6213–6221;.
Information & Authors
Information
Published In
OMICS: A Journal of Integrative Biology
Volume 26 • Issue Number 9 • September 2022
Pages: 473 - 488
PubMed: 36040392
Copyright
Copyright 2022, Mary Ann Liebert, Inc., publishers.
History
Published online: 7 September 2022
Published in print: September 2022
Published ahead of print: 30 August 2022
Topics
Authors
Author Disclosure Statement
The authors declare they have no conflicting financial interests.
Funding Information
The authors received no funding support from an external source.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.